Sanjay Chanda

Affiliations

  • Chief Development Officer at An2 Therapeutics Inc. (ANTX), 2025-02-28
  • Svp, Drug Development at Anacor Pharmaceuticals Inc. (ANAC), 2015-03-05
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ANTX $1.34 2,957 $3,965.34 29,824 2025-01-03 Filing
ANAC $45.00 48 $2,160.00 29,087 2015-03-04 Filing
ANAC $45.00 4,952 $222,840.00 29,087 2015-03-04 Filing
ANAC $35.00 5,000 $175,000.00 3,995 2014-11-26 Filing
ANAC $24.25 4,953 $120,110.25 3,995 2014-09-10 Filing